Please login to the form below
NIHR launches new framework to highlight health progress outcomes
Over 400 partners and stakeholders collaborated to develop the new framework
New diagnosis pathway has been launched to mark European Myeloma Day
The Myeloma Diagnosis Pathway aims to improve early diagnosis for patients
CDC provides $262.5m to create national network for infectious diseases
The OADMN aims to improve responses to outbreaks and prevent future pandemics
Alzheimer’s Research UK launches ‘Change The Ending’ campaign
A survey revealed that 22% of 2,162 people were unaware of the impact dementia has on people’s everyday lives
CDC awards over $23m to Johns Hopkins Center for Health Security project
The five-year grant will be used to help launch a new epidemic preparedness project
CSL Seqirus highlights impact of flu vaccines on reducing strain on healthcare resources
Flu vaccines for older adults in France could reduce hospitalisations by up to 30%
Moderna’s XBB.1.5-adapted COVID-19 vaccine receives MHRA approval
The vaccine has been updated to target the currently circulating XBB.1.5 Omicron variant
NHS bookings for COVID-19 vaccinations open as winter programme starts early
Millions of people in England are now eligible to receive flu and COVID-19 vaccines
Clinigen launches educational programme for rare disease patients and organisations
The NaviGATE programme will aim to empower patients and provide navigational support
Italy accelerates the path towards digital therapeutics implementation
PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy
-
Who's calling the shots in European healthcare?Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
-
The shifting healthcare landscape
-
FDA boosts collaboration with manufacturers to overcome ongoing cancer drug shortagesThe supply of cisplatin, carboplatin and methotrexate has nearly halved in the past year
-
US CDC recommends updated COVID-19 vaccines for autumn/winter seasonPfizer/BioNTech and Moderna’s updated vaccines will be available in the coming days
-
World Atopic Eczema Day 2023: Almirall unveils awareness campaignThe inflammatory skin disease is estimated to affect 4.4% of adults in the EU
-
FDA approves Pfizer/BioNTech and Moderna’s updated COVID-19 vaccines
The vaccines have both been adapted to target the currently circulating XBB.1.5 Omicron variant
-
NHS England winter flu and COVID-19 vaccine programmes start earlyThose who are eligible will be offered a vaccination from 18 September 2023 onwards
-
Pfizer and BioNTech’s XBB.1.5-adapted COVID-19 vaccine approved by MHRAThe updated vaccine proved effective against the currently circulating XBB.1.5 subvariant
-
Novartis sues US government over Medicare drug price negotiation programmeThe action comes after the first drugs subject to pricing negotiations were announced
-
Lilly announces two new senior leadership hiresRachel Batterham and Emily Pegg join as senior VP and associate VP respectively
-
Hanover appoints Ian Dodge to its senior adviser panelDodge was the former national director of strategy, primary care and community services for NHS England
-
NHS England appoints Chris Hopson as its new chief strategy officerHopson previously served as chief executive of NHS Providers
-
David Hunt launches independent agency The ConsideredThe team includes Professor Shafi Ahmed, Aurora Archer, Jane Kidd and CCO Pete Armstrong
-
Amanda Pritchard becomes NHS England’s first female chief executivePritchard takes on the chief executive role after serving as the NHS’ chief operating officer for two years
Latest healthcare appointments
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
AMICULUM
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
